TT
Turn Therapeutics Inc.
SEC filingBiotechnology · Westlake Village, CA
Amount raised$1.7Msold at filing
Total offeringNot stated
Investors in the raise8count reported to the SEC
FiledAug 26, 2026first sale Aug 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Martin William DewhurstDirector
Kent F KesterDirector
Andrew William GengosDirector
Bradley BurnamExecutive Officer, Director
Neilesh Shailesh GhodadraExecutive Officer, Director
Arthur F GoldenDirector
Zuraiz ChaudharyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.